Tilray

(NASDAQ: TLRY)
Healthcare  |  Drug Manufacturers—Specialty & Generic
5.62 -0.2411 -4.11%
Stock Price | Oct. 27, 2020, 2:58 p.m.
6 Followers
Bid: 5.61
Ask: 5.62
Prev. Close: 5.86
52 Week Low: 2.43
52 Week High: 24.75
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tilray, headquartered in Nanaimo, Canada, cultivates and sells medical and recreational cannabis through a portfolio of brands that include Canaca, Dubon, and Manitoba Harvest. The bulk of Tilray's sales are in Canada, but the company also sells CBD Products in the U.S. and exports medical cannabis globally from its production facilities in Canada and Portugal. Tilray also has a joint venture partnership with AB InBev to develop cannabis-infused drinks.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 10/27/20

4 Comments
20 hours ago

Premium Cannabis Stocks Review - Pre-Market Edition 10/23/20

2 Comments
4 days ago

Premium Cannabis Stocks Review - AM Edition 10/21/20

11 Comments
6 days ago

Premium Cannabis Stocks Review - Pre-Market Edition 10/20/20

4 Comments
1 week ago

Premium Cannabis Stocks Review - Power Hour Preview Edition 10/19/20

14 Comments
1 week ago

Premium Cannabis Stocks Review - AM Edition 10/19/20

44 Comments
1 week ago

Premium Weekly Review 10/16/20

1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 10/16/20

8 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 10/09/20

7 Comments
2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 10/06/20

4 Comments
3 weeks ago